239 related articles for article (PubMed ID: 7697592)
1. Colorectal cancer in patients with ulcerative colitis. A prospective cohort study in Italy.
Biasco G; Brandi G; Paganelli GM; Rossini FP; Santucci R; Di Febo G; Miglioli M; Risio M; Morselli Labate AM; Barbara L
Cancer; 1995 Apr; 75(8):2045-50. PubMed ID: 7697592
[TBL] [Abstract][Full Text] [Related]
2. Studies in longstanding ulcerative colitis with special reference to malignant transformation of the colorectal mucosa.
Löfberg R
Acta Chir Scand Suppl; 1989; 552():1-45. PubMed ID: 2800882
[TBL] [Abstract][Full Text] [Related]
3. Dysplasia and carcinoma in longstanding ulcerative colitis: an endoscopic and histological surveillance programme.
Leidenius M; Kellokumpu I; Husa A; Riihelä M; Sipponen P
Gut; 1991 Dec; 32(12):1521-5. PubMed ID: 1773959
[TBL] [Abstract][Full Text] [Related]
4. Dysplasia in ulcerative colitis--clinical consequences?
Sjöqvist U
Langenbecks Arch Surg; 2004 Oct; 389(5):354-60. PubMed ID: 15605166
[TBL] [Abstract][Full Text] [Related]
5. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.
Lindberg BU; Broomé U; Persson B
Dis Colon Rectum; 2001 Jan; 44(1):77-85. PubMed ID: 11805567
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer and high grade dysplasia complicating ulcerative colitis in Italy. A retrospective co-operative IG-IBD study.
Riegler G; Bossa F; Caserta L; Pera A; Tonelli F; Sturniolo GC; Oliva L; Contessini Avesani E; Poggioli G;
Dig Liver Dis; 2003 Sep; 35(9):628-34. PubMed ID: 14563184
[TBL] [Abstract][Full Text] [Related]
7. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
Navaneethan U; Kochhar G; Venkatesh PG; Bennett AE; Rizk M; Shen B; Kiran RP
J Crohns Colitis; 2013 Dec; 7(12):974-81. PubMed ID: 23523416
[TBL] [Abstract][Full Text] [Related]
8. Most dysplasia in ulcerative colitis is visible at colonoscopy.
Rutter MD; Saunders BP; Wilkinson KH; Kamm MA; Williams CB; Forbes A
Gastrointest Endosc; 2004 Sep; 60(3):334-9. PubMed ID: 15332019
[TBL] [Abstract][Full Text] [Related]
9. Colonoscopic surveillance in long-standing total ulcerative colitis--a 15-year follow-up study.
Löfberg R; Broström O; Karlén P; Tribukait B; Ost A
Gastroenterology; 1990 Oct; 99(4):1021-31. PubMed ID: 2394325
[TBL] [Abstract][Full Text] [Related]
10. Real-life chromoendoscopy for dysplasia surveillance in ulcerative colitis.
Klepp P; Tollisen A; Røseth A; Cvancarova Småstuen M; Andersen SN; Vatn M; Moum BA; Brackmann S
World J Gastroenterol; 2018 Sep; 24(35):4069-4076. PubMed ID: 30254411
[TBL] [Abstract][Full Text] [Related]
11. Cancer surveillance in ulcerative colitis.
Nugent FW; Haggitt RC; Gilpin PA
Gastroenterology; 1991 May; 100(5 Pt 1):1241-8. PubMed ID: 2013371
[TBL] [Abstract][Full Text] [Related]
12. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
[TBL] [Abstract][Full Text] [Related]
13. Dysplasia is more common in the distal than proximal colon in ulcerative colitis surveillance.
Goldstone R; Itzkowitz S; Harpaz N; Ullman T
Inflamm Bowel Dis; 2012 May; 18(5):832-7. PubMed ID: 21739534
[TBL] [Abstract][Full Text] [Related]
14. Results of cancer surveillance in ulcerative colitis.
Suzuki K; Muto T; Shinozaki M; Higuchi Y; Sawada T; Saito Y
J Gastroenterol; 1995 Nov; 30 Suppl 8():40-2. PubMed ID: 8563886
[TBL] [Abstract][Full Text] [Related]
15. Full-Spectrum Endoscopy Improves Surveillance for Dysplasia in Patients With Inflammatory Bowel Diseases.
Leong RW; Ooi M; Corte C; Yau Y; Kermeen M; Katelaris PH; McDonald C; Ngu M
Gastroenterology; 2017 May; 152(6):1337-1344.e3. PubMed ID: 28126349
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis.
Connell WR; Lennard-Jones JE; Williams CB; Talbot IC; Price AB; Wilkinson KH
Gastroenterology; 1994 Oct; 107(4):934-44. PubMed ID: 7926483
[TBL] [Abstract][Full Text] [Related]
17. How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance.
Eaden JA; Ward BA; Mayberry JF
Gastrointest Endosc; 2000 Feb; 51(2):123-8. PubMed ID: 10650251
[TBL] [Abstract][Full Text] [Related]
18. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.
Mpofu C; Watson AJ; Rhodes JM
Cochrane Database Syst Rev; 2004; (2):CD000279. PubMed ID: 15106148
[TBL] [Abstract][Full Text] [Related]
19. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
20. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis.
Rutter MD; Saunders BP; Schofield G; Forbes A; Price AB; Talbot IC
Gut; 2004 Feb; 53(2):256-60. PubMed ID: 14724160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]